Zydus Cadila acquires six brands from Merck
Drugmaker Cadila Healthcare, which operates under the brand Zydus Cadila, said it has acquired six brands from global drug giant Merck for an undisclosed amount as the company seeks to strengthen its portfolio in the therapeutic segment.
The six brands -- Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten -- fall in the men’s and women’s health, wound management and cardiovascular therapy segments. These brands clocked in sales of Rs 84 crore in 2015.
This is the second known sale of some its brands by MSD in India as it aims to focus on select core brands. In December 2015, the company sold five over-the-counter brands to Piramal Enterprises Ltd for Rs 92 crore.